LIFE:CA:TSX-Evolve Global Healthcare Enhanced Yield Fund Hedged Units (CAD)

ETF | Sector Equity |

Last Closing

CAD 22.22

Change

-0.11 (-0.49)%

Market Cap

CAD 0.22B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-23 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

-0.11 (-0.28%)

CAD 2.88B
ZWU:CA BMO Covered Call Utilities ETF

+0.07 (+0.58%)

CAD 1.93B
XHC:CA iShares Global Healthcare (CAD..

-0.20 (-0.26%)

CAD 0.66B
TXF:CA First Asset Tech Giants Covere..

-0.48 (-2.18%)

CAD 0.64B
XIT:CA iShares S&P/TSX Capped Informa..

+0.33 (+0.58%)

CAD 0.63B
HTA:CA Harvest Tech Achievers Growth ..

+0.02 (+0.11%)

CAD 0.62B
ZUT:CA BMO Equal Weight Utilities Ind..

+0.20 (+0.90%)

CAD 0.45B
CWW:CA iShares Global Water Common Cl..

+0.01 (+0.02%)

CAD 0.34B
XUT:CA iShares S&P/TSX Capped Utiliti..

+0.21 (+0.75%)

CAD 0.32B
COW:CA iShares Global Agriculture Com..

-0.08 (-0.13%)

CAD 0.28B

ETFs Containing LIFE:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.88% 26% F 38% F
Dividend Return 1.54% 63% D 42% F
Total Return 8.42% 29% F 38% F
Trailing 12 Months  
Capital Gain 6.06% 17% F 28% F
Dividend Return 1.53% 50% F 32% F
Total Return 7.59% 14% F 28% F
Trailing 5 Years  
Capital Gain 12.51% 20% F 47% F
Dividend Return 6.41% 40% F 21% F
Total Return 18.91% 17% F 44% F
Average Annual (5 Year Horizon)  
Capital Gain 0.96% 17% F 41% F
Dividend Return 2.09% 11% F 39% F
Total Return 1.13% 53% F 38% F
Risk Return Profile  
Volatility (Standard Deviation) 6.94% 97% N/A 81% B-
Risk Adjusted Return 30.11% 26% F 50% F
Market Capitalization 0.22B 62% D 47% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.